News | April 28, 2008

New Device Designed to Lower High Blood Pressure

April 28, 2008 - CVRx introduced a new device for high blood pressure engineered to treat hypertension patients whose conditions are not controlled by drugs, and aims to reduce systolic blood pressure.

Rheos Hypertension (HT) Therapy, which is now in clinical trials, is an implantable device and uses the body's natural blood pressure sensor (the baroreflex) to reduce blood pressure. Early hypertension clinical trial results showed a 39 mmHg reduction in systolic blood pressure at one year of use.

The Rheos HT Therapy is designed to electrically activate the carotid baroreceptors. When the baroreceptors are activated, signals are sent through the neural pathways to the brain and interpreted as a rise in blood pressure. The brain works to counteract this perceived rise in blood pressure by sending signals to various parts of the body, including the blood vessels, heart and kidneys.

For more information: www.cvrx.com and www.bloodpressuretrial.com

Related Content

SunTech Medical Receives Third-Party Validation of CT40 BP Spot-Check Device
News | Blood Pressure Monitor| October 11, 2017
October 11, 2017 — The CT40 spot-check device from SunTech Medical has received third-party validation for...
Suntech Medical, Oscar 2 ambulatory blood pressure monitoring system, ABPM, Patient Diary App, SphygmoCor Inside
Technology | Blood Pressure Monitor| January 17, 2017
The new SunTech Oscar 2 24-hour ambulatory blood pressure monitoring system is now available with the True24 ABPM...
Sponsored Content | Videos | Blood Pressure Monitor| March 26, 2013
SunTech demonstrated its new Tango M2 cardiac stress test automated blood pressure monitoring system at the American
Overlay Init